Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
setidegrasib (ASP3082)
i
Other names:
ASP3082, ASP 3082, ASP-3082
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(4)
News
Trials
Company:
Astellas
Drug class:
KRAS G12D degrader
‹
›
Associations
(4)
News
Trials
VERI cancer hierarchy
Reset Filters
KRAS G12D
Pancreatic Cancer
KRAS G12D
Pancreatic Cancer
ASP3082
Sensitive: D – Preclinical
ASP3082
Sensitive
:
D
ASP3082
Sensitive: D – Preclinical
ASP3082
Sensitive
:
D
KRAS G12D
Colorectal Cancer
KRAS G12D
Colorectal Cancer
ASP3082
Sensitive: D – Preclinical
ASP3082
Sensitive
:
D
ASP3082
Sensitive: D – Preclinical
ASP3082
Sensitive
:
D
KRAS G12D
Non Small Cell Lung Cancer
KRAS G12D
Non Small Cell Lung Cancer
ASP3082
Sensitive: D – Preclinical
ASP3082
Sensitive
:
D
ASP3082
Sensitive: D – Preclinical
ASP3082
Sensitive
:
D
KRAS G12D
Pancreatic Ductal Adenocarcinoma
KRAS G12D
Pancreatic Ductal Adenocarcinoma
ASP3082
Sensitive: D – Preclinical
ASP3082
Sensitive
:
D
ASP3082
Sensitive: D – Preclinical
ASP3082
Sensitive
:
D
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.